A natural history of apical hypertrophic cardiomyopathy with development of an apical aneurysm formation: A case report following a quarter century  by Kawai, Keisuke et al.
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We  report  the deﬁnite  long-term  natural  history  of  a man  with  apical  hypertrophic  cardiomyopathy
(ApHCM),  who  developed  an apical  aneurysm  by  the age  of  60 years.  At  33 years,  his  electrocardiogram
(ECG)  was  nearly  normal.  T-wave  inversions  were  ﬁrst  identiﬁed  in  leads  V5–6  of an  ECG  at  36 years
of  age.  Echocardiography  ﬁrst demonstrated  a left ventricular  (LV)  lateral  wall  hypertrophy  at  37 years
of  age.  At  42  years,  echocardiography  showed  the  pattern  of  diastolic  spade-like  appearance  of  the  LV
cavity,  conﬁrming  the ApHCM  diagnosis.  At  54  years,  a late-peaking  apical  systolic  gradient  of  10  mmHg
(velocity:  1.6  m/s)  emerged.  At 60 years,  he  had  developed  an  apical  aneurysm.  Cardiac  computed  tomo-
graphy  revealed  no signiﬁcant  major  coronary  artery  stenosis.  Thus,  in  our case,  LV  hypertrophy  and
apical  high  pressure  in ApHCM  advanced  the formation  of  an  apical  aneurysm  in the absence  of  coronary
artery  disease.chocardiography <Learning  objective:  High  apical  systolic  ﬂow  velocity  of  ≥1.5  m/s  in  apical  hypertrophic  cardiomy-
opathy  (ApHCM)  using  echocardiography  may  be  predictive  of  the  development  of  apical  aneurysm,
and  make  us consider  medical  intervention  by  beta-blockers  or verapamil  to  delay  or prevent  aneurysm
formation.  Because  recent  studies  have  demonstrated  that  ApHCM  may  be  less benign  than  previously
suspected,  observation  without  medical  attention  for  ApHCM  might  be hazardous.>
©  2014  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.ntroduction
Apical hypertrophic cardiomyopathy (ApHCM) is a variant of
ypertrophic cardiomyopathy. ApHCM is characterized by myocar-
ial hypertrophy occurring predominantly in the left ventricular
LV) apical portion, with giant negative T waves (>10 mm)  in the
eft precordial leads of the electrocardiogram (ECG) [1]. Although
atients with ApHCM sometimes develop apical aneurysm, the
eﬁnite long-term natural history of ApHCM has not been
lariﬁed.
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Here, we  report the case of a 61-year-old man without a history
of essential hypertension and with a history of diabetes, bronchial
asthma, and duodenal ulcer. He had no family history of sud-
den death or hypertrophic cardiomyopathy. The patient measured
163 cm in height and 53 kg in weight. His blood pressure was
106/80 mmHg  and the heart rate was  55 beats/min.
The natural history of the patient from 33 years of age to 61
years follows:
At  33 years of age, the patient’s ECG was nearly normal (Fig. 1).
At  36 years of age, T-wave inversions were ﬁrst identiﬁed in the
left precordial leads V5–6 of the ECG during a routine examination
of the patient. No abnormality was  documented at that time by
echocardiography.
At 37 years of age, with T-wave inversions in leads V4–6 of
the ECG (Figs. 1 and 2), the echocardiography ﬁrst demonstrated
served.
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At 60 years of age, a follow-up echocardiogram demonstratedFig. 1. Serial 12-lead electrocardiogram recording, showing the development an
V lateral wall hypertrophy, with a wall thickness of 13 mm
Fig. 3).
At  42 years of age, the left precordial R waves and negative T
aves reached their maximal amplitude (Figs. 1 and 2). Echocar-
iography showed the pattern of diastolic spade-like appearance
f the LV cavity with severe apical hypertrophy, conﬁrming the
iagnosis of ApHCM. The early diagnosis of ApHCM can be achieved
y identifying the hypertrophy that is frequently conﬁned to the
ateral wall at the apical level using magnetic resonance imaging
2]. However, in this case, due to the limited image quality of
arly echocardiographic studies, the severity of the LV lateral wall
ypertrophy was assessed in the parasternal short-axis plane at
he level of the papillary muscles using echocardiography (Fig. 3).
s shown in Fig. 3, his lateral wall hypertrophy at the papillary
uscles level developed over a 25-year period, but he did not
ig. 2. Changes in electrocardiogram in lead V4 with age. Depth of the negative
-wave  in lead V4 initially increased and then decreased. The presence of giant
egative  T-waves (>10 mm)  was shown for the ﬁrst time at 38 years of age. R-wave
oltage  also progressively increased and then decreased.nuation of deep T-wave inversions in leads I, aVL, and V3–6 with sinus rhythm.
demonstrate basal interventricular septal hypertrophy of ≥15 mm.
Therefore, he was  classiﬁed as having the apical phenotype with
the “distal-dominant” form [3]: apical hypertrophy extended to
the lateral wall and interventricular septum beyond the papillary
muscles level without basal septal hypertrophy.
At 54 years of age, a late-peaking apical systolic gradient of
10 mmHg  (velocity: 1.6 m/s) and a diastolic gradient from apex
to base, which generated a paradoxical jet ﬂow [4], developed
between the apical and basal chambers (Figs. 3 and 4).
At  55 years of age, a non-sustained ventricular tachycardia of
four consecutive extrasystoles was  revealed in the Holter recording.that the patient had developed an apical aneurysm. Enhanced com-
puted tomography (CT) also showed an apical aneurysm formation
Fig. 3. Changes in echocardiogram measurements with age, showing mild thicken-
ing of the basal interventricular septum () and the basal left ventricular posterior
wall  (). Lateral wall hypertrophy at the level of the papillary muscles () developed
over  a 25-year period. Using Doppler measurement, the apical systolic ﬂow velocity
() was up to 1.7 m/s  (pressure gradient: 12 mmHg) at 55 years of age.
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Fig. 4. Changes in Doppler imaging with age, showing an apical systolic gradient (arrows). The peak systolic velocity at the left ventricular apex increased from 1.2 m/s  (at
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(9  years of age) to 1.6 m/s  (at 54 years of age). The image at 54 years of age shows a
ase  (arrow head), generating a paradoxical jet ﬂow. By 60 years of age, the apical 
he  simpliﬁed Bernoulli equation. Three images were adjusted to the same velocity
n ApHCM (Fig. 5). At that time, the apical systolic gradient had
isappeared (Fig. 4). By echocardiography, the LV end-diastolic
imension was 50 mm,  the left atrial dimension was 40 mm,  the
ractional shortening was 38%, and the early to atrial transmi-
ral peak velocity ratio was 1.34. His plasma B-type natriuretic
eptide concentration was 35 pg/mL. Cardiac CT revealed no signif-
cant major coronary artery stenosis besides suspicion of a diagonal
ranch stenosis. Upon exercise thallium single-photon emission
omputed tomography (201Tl-SPECT), the patient exhibited a ﬁxed
erfusion defect with no redistribution in the apical segment.
During  the whole follow-up period, the clinical course was sta-
le and uneventful without clinical, ECG, or enzymatic evidence of
yocardial infarction. Therefore, the patient did not receive medi-
al treatment for ApHCM.
At  61 years of age, a non-sustained monomorphic ventricular
achycardia of 11 consecutive extrasystoles without symptoms was
evealed in the Holter recording, and cardiac magnetic resonance
ig. 5. Enhanced computed tomography showing the apical aneurysm formation
arrow)  in apical hypertrophic cardiomyopathy.eaking systolic gradient of 10 mmHg (arrow), and a diastolic gradient from apex to
ic gradient had disappeared. The apical intraventricular gradient was  estimated by
was performed to deﬁne his myocardial ﬁbrosis and scarring. As
shown in Fig. 6, there was a transmural late gadolinium enhance-
ment (consistent with myocardial ﬁbrosis) of the aneurysmal rim
with extension into substantial areas of mid-myocardium in the
anterior wall. He is now under consideration for a prophylactic
implantable cardioverter-deﬁbrillator.
Discussion
To  the best of our knowledge, this is the ﬁrst report of the deﬁnite
long-term natural history of ApHCM with the development of an
apical aneurysm formation. In the present case, the left precordial
R waves and negative T waves progressed in the initial develop-
mental stage of this condition, reaching their maximal amplitude
at approximately the time of diagnosis, and underwent further evo-
lutional changes resulting in the disappearance of the characteristic
tall R waves and giant negative T waves (Fig. 2). Previously, Webb
et al. [5] described that in ApHCM patients who had more than 10
years of follow-up ECGs, precordial T wave inversions progressed
from −0.8 ± 3.9 to −11.2 ± 8.0 mm.  Later, Koga et al. [6] reported
that giant negative T waves disappeared in 71% of ApHCM patients
who were followed for ≥10 years. In our case, reported here, both
“wax and wane” phenomena [1] of R waves and negative T waves
were completed throughout the entire course.
As shown in Figs. 2 and 3, the ECG abnormalities with high
R wave amplitude and marked T-wave inversion evolved before
the echocardiogram demonstrated LV hypertrophy, which contin-
ued after the disappearance of high R waves and giant negative
T waves. Similarly, Maron et al. [7] reported that distinctive elec-
trocardiographic patterns with marked T-wave inversion preceded
the appearance of the hypertrophic cardiomyopathy phenotype on
the imaging studies.
Myocardial infarction-like ﬁndings or aneurysm formation has
been reportedly observed in approximately 10% of ApHCM [8,9].
Furthermore, the formation of apical outpouching or aneurysm
may be detected in up to 30% of cases of ApHCM, using advanced
imaging modalities [10]. Similar to our case, angiographically nor-
mal  coronary arteries have been conﬁrmed in 90% of patients with
ApHCM and myocardial infarction-like ﬁndings [8].At  60 years of age, the patient in this study developed an api-
cal aneurysm 22 and 11 years after the initial diagnosis and the
disappearance of giant negative T-waves, respectively (Fig. 2). As
previously reported [6,8], the disappearance of the giant negative
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Fig. 6. Left ventricular scarring associated with apical aneurysm formation. (A and B) Cine noncontrast two-chamber long-axis and equatorial short-axis cardiac magnetic
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oesonance images, respectively. (C and D) Identical imaging views after intraveno
consistent with myocardial ﬁbrosis) of the aneurysmal rim (arrowheads in C) with
 and D).
-waves may  be a step in the progression of the disease, leading
o silent aneurysm formation. Also, being less than 41 years of age
t the time of presentation was a predictor of apical myocardial
nfarction-like ﬁndings including aneurysms in ApHCM [8], as in
ur case.
This is the ﬁrst case study to report the serial apical ﬂow veloc-
ty measurements using Doppler echocardiography in ApHCM with
he development of an apical aneurysm over 10 years. Apical sys-
olic gradients of 10 mmHg  (peak velocity: 1.6 m/s) developed 6
ears before the detection of the apical aneurysm in our case
Figs. 3 and 4). In another report [11], the LV systolic gradients of
5 mmHg  (2.5 m/s) emerged 2 years before the detection of the
pical aneurysm. According to Ishiwata et al. [9], in three of the
ve ApHCM patients who progressed to apical aneurysm, new api-
al pressure gradients developed (0 → 35 ± 14 mmHg) at the time
f the detection of the apical aneurysm. In the remaining two
atients with ApHCM and apical aneurysm who did not show apical
ressure gradients, we speculate that apical gradients might have
merged before the detection of the aneurysm and disappeared
hereafter, as in our case. According to Nakamura et al. [4], the
pical systolic ﬂow velocity in eight ApHCM patients with para-
oxical jet ﬂow, which may  contribute to the development of an
pical aneurysm, ranged from 1.4 to 3.7 m/s  (mean: 2.4 ± 0.8 m/s).
herefore, an apical systolic ﬂow velocity ≥1.5 m/s  might be a
ood predictor of the future development of an apical aneurysm
n ApHCM.
Previously, Eriksson et al. [8] reported that although ApHCM has
 benign prognosis in terms of cardiovascular mortality, cardio-
ascular morbidity of ApHCM was not, as 30% of ApHCM patients
eveloped morbid events such as atrial ﬁbrillation, myocardial
nfarction-like ﬁndings, and strokes. Furthermore, recent studies
ave demonstrated that ApHCM may  be less benign than previ-
usly suspected [12–14]. The overall survival rate of ApHCM was  as
igh as that of asymmetric hypertrophic cardiomyopathy [14]. Clin-
cally important cardiovascular events, including cardiovascular
eath, overt heart failure, and stroke, occurred in 25% of the ApHCM
atients during 43 ± 20 months of follow-up [13]. In addition, as
upposed by our case (Fig. 6), late gadolinium enhancement incre-
ent seems to be more extensive in ApHCM than in other patterns
f hypertrophic cardiomyopathy [15]. Apical aneurysm formationntrast injection of gadolinium showing transmural late gadolinium enhancement
sion into substantial areas of the mid-myocardium in the anterior wall (arrows in
in  ApHCM patients is sometimes associated with severe arrhyth-
mia [8,11], thrombus formation [4,9,11], cerebral infarction [9], and
sudden cardiac death [16]. The speciﬁc treatment of patients with
ApHCM is not well deﬁned. However, given the severe cavity oblit-
eration and presence of an intra-ventricular pressure gradient, the
use of beta-blockers [14,17,18] or verapamil [19] may be warranted.
Detection of apical high pressure could signal earlier intervention
of medical therapy in an effort to prevent the development of a true
aneurysm.
Conclusion
In our case study, LV hypertrophy and apical high pressure
in ApHCM advanced the formation of an apical aneurysm in
the absence of coronary artery disease. High apical systolic ﬂow
velocity of ≥1.5 m/s  in ApHCM using echocardiography may be
predictive of the development of apical aneurysm, and make us
consider medical intervention by beta-blockers or verapamil to
delay or prevent aneurysm formation. Observation without medi-
cal attention for ApHCM might be hazardous.
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